173 related articles for article (PubMed ID: 15937504)
61. Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Yamasaki S; Heike Y; Mori S; Fukuda T; Maruyama D; Kato R; Usui E; Koido K; Kim S; Tanosaki R; Tobinai K; Teshima T; Takaue Y
Transpl Infect Dis; 2008 Jul; 10(4):252-9. PubMed ID: 18194371
[TBL] [Abstract][Full Text] [Related]
62. Penicillium marneffei fungaemia in an allogeneic bone marrow transplant recipient.
Woo PC; Lau SK; Lau CC; Chong KT; Hui WT; Wong SS; Yuen KY
Bone Marrow Transplant; 2005 Apr; 35(8):831-3. PubMed ID: 15765113
[No Abstract] [Full Text] [Related]
63. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
[TBL] [Abstract][Full Text] [Related]
64. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
[TBL] [Abstract][Full Text] [Related]
65. Reconstitution of T cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation.
Friedman TM; Azhipa O; Zilberberg J; Tkachuk Y; Hsu JW; Rowley SD; Goldberg SL; Korngold R; Pecora AL; Preti RA
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1092-5. PubMed ID: 17084373
[No Abstract] [Full Text] [Related]
66. Splenectomy may reverse pancytopenia occurring after allogeneic bone marrow transplantation.
von Bueltzingsloewen A; Bordigoni P; Dorvaux Y; Witz F; Schmitt C; Chastagner P; Sommelet D
Bone Marrow Transplant; 1994 Aug; 14(2):339-40. PubMed ID: 7994254
[No Abstract] [Full Text] [Related]
67. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
68. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
69. Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course.
Kochethu G; Baden HS; Jaworska E; Chang J; Chopra R
Bone Marrow Transplant; 2005 Jul; 36(1):81-2. PubMed ID: 15895117
[No Abstract] [Full Text] [Related]
70. The consequences of tacrolimus blood concentrations during the four weeks following marrow transplantation from an unrelated donor: a single-center experience.
Muta T; Kato K; Gondo H; Oku S; Okeda A; Kamo M; Nawata R; Takase K; Arima F; Shibuya T; Eto T
Gan To Kagaku Ryoho; 2008 Jan; 35(1):99-104. PubMed ID: 18195535
[TBL] [Abstract][Full Text] [Related]
71. Fulminant hepatic failure caused by adenovirus infection following bone marrow transplantation for Hodgkin's disease.
Somervaille TC; Kirk S; Dogan A; Landon GV; Mackinnon S
Bone Marrow Transplant; 1999 Jul; 24(1):99-101. PubMed ID: 10435743
[TBL] [Abstract][Full Text] [Related]
72. Acute myocardial infarction in a 16-year-old girl with chronic GVHD.
Miura T; Izawa A; Kumazaki S; Ishii E; Otagiri K; Aizawa K; Koshikawa M; Kasai H; Tomita T; Miyashita Y; Tsutsui H; Koyama J; Ikeda U
Bone Marrow Transplant; 2010 Oct; 45(10):1576-7. PubMed ID: 20173788
[No Abstract] [Full Text] [Related]
73. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Kröger N; Shimoni A; Zabelina T; Schieder H; Panse J; Ayuk F; Wolschke C; Renges H; Dahlke J; Atanackovic D; Nagler A; Zander A
Bone Marrow Transplant; 2006 Feb; 37(4):339-44. PubMed ID: 16415898
[TBL] [Abstract][Full Text] [Related]
74. Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.
de Lissovoy G; Hurd D; Carter S; Beatty P; Ewell M; Henslee-Downey J; Kernan N; Yanovich S; Weisdorf D
Bone Marrow Transplant; 2005 Sep; 36(6):539-46. PubMed ID: 16044144
[TBL] [Abstract][Full Text] [Related]
75. Mucormycosis: a rare but serious infection.
Eichna DM; Brown KS; Breen A; Dean RB
Clin J Oncol Nurs; 2008 Feb; 12(1):108-12. PubMed ID: 18258580
[TBL] [Abstract][Full Text] [Related]
76. Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning.
Cutting R; Ezaydi Y; Edbrooke D; El-Ghariani K; Stamps R; Snowden JA
Bone Marrow Transplant; 2006 Aug; 38(4):317-8. PubMed ID: 16819439
[No Abstract] [Full Text] [Related]
77. Severe disseminated toxoplasmosis after unrelated bone marrow transplantation: a case report.
Longoni DV; Fumagalli R; Fumagalli M; Cappellini A; Uderzo C
Haematologica; 2000 Jul; 85(7):781-2. PubMed ID: 10897145
[No Abstract] [Full Text] [Related]
78. Successful treatment of autoimmune hemolytic anemia with rituximab in a child with severe combined immunodeficiency following nonidentical T-cell-depleted bone marrow transplantation.
Bonduel M; Zelazko M; Figueroa C; Magaldi G; Rossi J; del Pozo A
Bone Marrow Transplant; 2005 Apr; 35(8):819-21. PubMed ID: 15750606
[No Abstract] [Full Text] [Related]
79. Long-term renal function following bone marrow transplantation.
Grönroos MH; Bolme P; Winiarski J; Berg UB
Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
[TBL] [Abstract][Full Text] [Related]
80. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
